Exicure, Inc. (XCUR)
1.25
+0.02
(+1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.23
-0.02
(-1.60%)
Pre-Market: 20:00
Exicure SG&A Expense (TTM) : 5.28M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.28M |
| March 31, 2026 | 5.905M |
| December 31, 2025 | 6.831M |
| September 30, 2025 | 6.674M |
| June 30, 2025 | 6.609M |
| March 31, 2025 | 6.33M |
| December 31, 2024 | 5.449M |
| September 30, 2024 | 5.503M |
| June 30, 2024 | 6.466M |
| March 31, 2024 | 10.87M |
| December 31, 2023 | 12.65M |
| September 30, 2023 | 13.26M |
| June 30, 2023 | 13.28M |
| March 31, 2023 | 10.84M |
| December 31, 2022 | 10.89M |
| September 30, 2022 | 12.93M |
| June 30, 2022 | 13.46M |
| March 31, 2022 | 13.36M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.09M |
| September 30, 2021 | 11.66M |
| June 30, 2021 | 11.14M |
| March 31, 2021 | 10.27M |
| December 31, 2020 | 9.955M |
| September 30, 2020 | 9.379M |
| June 30, 2020 | 9.183M |
| March 31, 2020 | 8.939M |
| December 31, 2019 | 8.573M |
| September 30, 2019 | 8.287M |
| June 30, 2019 | 7.978M |
| March 31, 2019 | 7.981M |
| December 31, 2018 | 7.818M |
| September 30, 2018 | 8.192M |
| June 30, 2018 | 7.543M |
| March 31, 2018 | 5.555M |
| December 31, 2017 | 3.51M |
| September 30, 2017 | 1.27M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 23.36M |
| Century Therapeutics, Inc. | 20.16M |
| Absci Corp. | 35.28M |
| Celularity, Inc. | 51.27M |
| Cardio Diagnostics Holdings, Inc. | 3.501M |